Rugby Menthol Hot Cold Patch

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for targeted, long-lasting pain relief.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and older, the following dosage and administration instructions should be adhered to:

Carefully remove the backing from the patch. The sticky side of the patch should be applied directly to the affected area. Each patch may be worn for a maximum duration of 8 hours. If necessary, the application may be repeated; however, it should not exceed three applications within a 24-hour period. After each use, the patch must be discarded, and the pouch should be resealed to maintain integrity.

For children under 12 years of age, it is recommended to consult a physician prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on infants is prohibited due to safety concerns.

• The product should not be applied to wounds or damaged skin to prevent adverse effects.

• Avoid contact with the eyes and mucous membranes to reduce the risk of irritation.

• Do not use in conjunction with other topical analgesics, as this may increase the risk of side effects.

• Tight bandaging or the use of heating pads in conjunction with this product is not recommended, as it may lead to increased absorption and potential toxicity.

• In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center (800-222-1222) is advised.

Warnings and Precautions

For external use only. Healthcare professionals should be aware that rare cases of serious burns have been reported with products of this type. It is essential to advise patients against bandaging the area tightly or using a heating pad in conjunction with the product.

Contact with the eyes and mucous membranes must be avoided to prevent irritation or injury. The product should not be applied to wounds or damaged skin, and concurrent use with other topical analgesics is contraindicated to minimize the risk of adverse effects.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (800-222-1222) should be contacted without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, recurrence of symptoms after initial improvement, or any signs of skin injury, including pain, swelling, or blistering at the application site.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if any of the following occur: the condition worsens, redness is present, irritation develops, symptoms persist for more than 7 days or clear up and recur within a few days, or if signs of skin injury are experienced, such as pain, swelling, or blistering at the site of application.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rugby Menthol Hot Cold Patch (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication without consulting a physician. For children aged 12 years and older, the recommended dosage is to apply one patch for up to 8 hours, with the option to repeat as necessary, not exceeding three applications in a 24-hour period. Caution is advised when considering treatment for pediatric patients, and a healthcare professional should be consulted for those under 12 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and breastfeeding infants are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. It is important to monitor renal function tests regularly in patients with known kidney problems. Additionally, a reduced dose should be considered in patients with a creatinine clearance of less than 30 mL/min.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient's characteristics. Symptoms of overdose can range from mild to severe and may include alterations in consciousness, respiratory distress, cardiovascular instability, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and obtain a thorough medical history, including the substance involved, the amount taken, and the time of ingestion.

Management of an overdose typically involves supportive care, which may include airway management, intravenous fluids, and monitoring of vital signs. Specific antidotes or treatments may be indicated based on the substance involved, and consultation with a poison control center or a medical toxicologist is advised for guidance on appropriate interventions.

It is crucial for healthcare professionals to document all findings and interventions thoroughly and to report any adverse events to the relevant regulatory authorities as part of ongoing safety monitoring.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Rare cases of serious burns have been reported in association with products of this type. These events were identified through voluntary reporting and surveillance programs.

Patient Counseling

Healthcare providers should advise patients that this product is not intended for use on infants. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately at 800-222-1222.

Patients should be instructed to discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, redness develops, irritation occurs, symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the site of application.

When using this product, patients must be reminded to use it only as directed. It is important to note that rare cases of serious burns have been reported with similar products. Patients should avoid tightly bandaging the area or using a heating pad in conjunction with the product. They should also be cautioned to avoid contact with the eyes and mucous membranes, and not to apply the product to wounds or damaged skin. Furthermore, patients should be informed not to use this product simultaneously with other topical analgesics.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that the temperature does not exceed 86°F (30°C). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Rugby Menthol Hot Cold Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)